Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Apr 25, 2017
Scale-up of a DPI carrier-based formulation and blending process optimization
Read more
Scientific Article
/ Apr 25, 2017
Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate
Read more
Scientific Article
/ Apr 25, 2017
Optimization of Formulation and Process Parameters for the Manufacture of Inhalable Composite Particles by Spray-Drying
Read more
Scientific Article